EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classes
暂无分享,去创建一个
Andrew H. Beck | Sheida Nabavi | Daniel Schmolze | Mayinuer Maitituoheti | Sadhika Malladi | A. Beck | D. Schmolze | M. Maitituoheti | S. Nabavi | Sadhika Malladi
[1] P. Polakis. Wnt signaling and cancer. , 2000, Genes & development.
[2] Leonidas J. Guibas,et al. The Earth Mover's Distance as a Metric for Image Retrieval , 2000, International Journal of Computer Vision.
[3] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[4] A. Shelling,et al. Role of p53 in drug resistance in ovarian cancer , 1997, The Lancet.
[5] David V Conti,et al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. , 2011, Human molecular genetics.
[6] Chakrabarti,et al. Augmented expression of endothelin‐1, endothelin‐3 and the endothelin‐B receptor in breast carcinoma , 2000, Histopathology.
[7] Hye-Sung Moon,et al. Immunohistochemical and quantitative competitive PCR analyses of midkine and pleiotrophin expression in cervical cancer. , 2003, Gynecologic oncology.
[8] O. H. Brownlee,et al. ACTIVITY ANALYSIS OF PRODUCTION AND ALLOCATION , 1952 .
[9] Piotr Zawierucha,et al. Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line , 2014, BioMed research international.
[10] Michael J. Becich,et al. Tests for finding complex patterns of differential expression in cancers: towards individualized medicine , 2004, BMC Bioinformatics.
[11] Fan Yang,et al. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis , 2014, Breast Cancer Research and Treatment.
[12] Malka Gorfine,et al. Comment on “ Detecting Novel Associations in Large Data Sets ” , 2012 .
[13] J. Willey,et al. Molecular Cancer Stable Low-level Expression of P21 Waf1/cip1 in A549 Human Bronchogenic Carcinoma Cell Line-derived Clones Down-regulates E2f1 Mrna and Restores Cell Proliferation Control , 2006 .
[14] A. Cheung,et al. Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression , 2012, PloS one.
[15] Debashis Ghosh,et al. COPA - cancer outlier profile analysis , 2006, Bioinform..
[16] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[18] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[19] Daniel Herr,et al. Local Renin-Angiotensin System in the Reproductive System , 2013, Front. Endocrinol..
[20] Y-H Wu,et al. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer , 2014, Oncogene.
[21] David J. Reiss,et al. Integrated biclustering of heterogeneous genome-wide datasets for the inference of global regulatory networks , 2006, BMC Bioinformatics.
[22] Sib Sankar Roy,et al. Wnt/β-Catenin Pathway Is Regulated by PITX2 Homeodomain Protein and Thus Contributes to the Proliferation of Human Ovarian Adenocarcinoma Cell, SKOV-3* , 2012, The Journal of Biological Chemistry.
[23] Tatsuo Kanda,et al. Fatty Acid Binding Protein 6 Is Overexpressed in Colorectal Cancer , 2006, Clinical Cancer Research.
[24] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[25] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[26] C A SALVATORE,et al. [Carcinoma of the ovary]. , 1960, Anais brasileiros de ginecologia.
[27] S. Cannistra,et al. Gene-expression profiling in epithelial ovarian cancer , 2008, Nature Clinical Practice Oncology.
[28] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[29] Leonidas J. Guibas,et al. A metric for distributions with applications to image databases , 1998, Sixth International Conference on Computer Vision (IEEE Cat. No.98CH36271).
[30] P Maisonneuve,et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[31] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[32] David H. Wolpert,et al. No free lunch theorems for optimization , 1997, IEEE Trans. Evol. Comput..
[33] Donald J Buchsbaum,et al. The Wnt/β-catenin pathway in ovarian cancer: a review. , 2013, Gynecologic oncology.
[34] R. Tibshirani,et al. Comment on "Detecting Novel Associations In Large Data Sets" by Reshef Et Al, Science Dec 16, 2011 , 2014, 1401.7645.
[35] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[36] Tian-Li Wang,et al. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. , 2012, Journal of the National Cancer Institute.
[37] T. Conrads,et al. Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes , 2013, British Journal of Cancer.
[38] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[39] Yihong Zhu,et al. Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression , 2006, Molecular Cancer.
[40] Tiffany M Hebert,et al. Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer , 2010, Clinical Cancer Research.
[41] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[42] Gloria S. Huang,et al. Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer , 2014, PloS one.
[43] John D. Storey. A direct approach to false discovery rates , 2002 .